iifl-logo

DSP Healthcare Fund Direct G

DSP Healthcare Fund Direct G

Fund Name

DSP Mutual Fund

Scheme Name

DSP Healthcare Fund Direct G

AMC

DSP Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

12-Nov-2018

Fund Manager

Chirag Dagli

Net Assets (Rs. cr)

2891.76

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

DSP Healthcare Fund Direct G - Nav Details

Nav Date

:  11-May-2026

NAV [Rs.]

:  44.583

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

1.00% - If redeemed/switched out within 12 months from the date of allotment. Nil - If redeemed/switched out after 12 months from the date of allotment.

DSP Healthcare Fund Direct G- NAV Chart

DSP Healthcare Fund Direct G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
2.77
9.04
9.19
1.45
10.74
24.17
15.57
22.26
Category Avg
3.34
9.41
8.43
6.09
14.6
25.33
14.5
15.34
Category Best
4.83
11.91
11.15
11.97
24.01
29.24
17
30.09
Category Worst
-0.76
5
1.45
-0.99
6.08
21.5
11.06
-0.57

DSP Healthcare Fund Direct G- Latest Dividends

No Records Found

DSP Healthcare Fund Direct G- Investment Details

Min. Investment(Rs.)

100

Increm.Investment(Rs.)

100

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology8.841535592277.68
EquityIpca Labs.Pharmaceuticals & Biotechnology8.261696381259.69
EquityCiplaPharmaceuticals & Biotechnology7.561813462237.49
Foreign EquityGlobus Medical IncHealthcare Equipment & Supplies7.35268800230.86
EquityLaurus LabsPharmaceuticals & Biotechnology6.421832618201.76
Foreign EquityIllumina IncHealthcare Services6.16160400193.61
EquitySai LifePharmaceuticals & Biotechnology6.101792251191.67
EquityGland PharmaPharmaceuticals & Biotechnology5.13920673161.19
EquityCohance LifePharmaceuticals & Biotechnology4.833140630151.77
EquityApollo HospitalsHealthcare Services4.73194767148.73
EquityAlembic PharmaPharmaceuticals & Biotechnology3.431428180107.82
EquityVijaya Diagnost.Healthcare Services3.36935530105.67
EquityPfizerPharmaceuticals & Biotechnology3.0120064494.51
EquityKovai MedicalHealthcare Services2.9716515693.43
EquityP & G Health LtdPharmaceuticals & Biotechnology2.6415928883.09
Foreign EquityIntuitive Surgical IncHealthcare Equipment & Supplies2.601876881.79
EquityIndoco RemediesPharmaceuticals & Biotechnology2.16323347467.73
EquityEmcure PharmaPharmaceuticals & Biotechnology2.0137669863.28
EquityConcord BiotechPharmaceuticals & Biotechnology1.8149668856.72
EquityICICI LombardInsurance1.3524141342.56
EquityNephrocare HealtHealthcare Services1.0763498333.60
EquityUnichem Labs.Pharmaceuticals & Biotechnology1.0685206333.23
EquityAarti DrugsPharmaceuticals & Biotechnology1.0285215532.06
Foreign EquityAbbott LaboratoriesPharmaceuticals & Biotechnology0.873160027.32
EquityAlkem LabPharmaceuticals & Biotechnology0.643733420.16
EquityMedplus HealthRetailing0.5319207816.75
EquityJupiter Life LinHealthcare Services0.379411711.53
EquityLaxmi DentalHealthcare Equipment & Supplies0.182804015.57
EquityCorona RemediesPharmaceuticals & Biotechnology0.15273144.71
Foreign EquityGrail IncHealthcare Services0.1487334.53

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
DSP Mutual Fund
Incorporation Date:
13-May-1996
Total Assets Managed (Cr.):
2,28,622.33
Trustee/s:
Mr.T.S. Krishna Murthy, DSP Trustee Private Limit, Shitin D. Desai, S.S.N. Moorthy, Mrs. Pravin tripathi, Ms. Dharmishta Rawal
Chairman:
NA
CEO / MD:
Mr. Kalpen Parekh
CIO:
NA
President:
NA
Director/s:
Uday Khanna, Mr.Hemendra M. Kothari, Mr. S.S. Mundra, Ms. Aditi Kothari Desai, Mr.Dhananjay Mungale, Mr. S. Ramadorai
Compliance Officer/s:
Pritesh Majmudar
Investor Service Officer/s:
NA
Fund Manager/s:
Chirag Dagli
Auditors:
S.R. BATLIBOI &Co.LLP, M/s.Walker Chandiok & Co.

OTHER INFORMATION

Registered Office:
The Ruby, 25th Floor, 29, Senapati Bapat Marg, Dadar (West), Mumbai - 400028.
Contact Nos:
022-66578000
Fax:
022-66578181
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.